$CRCT Cashflow Statement | Understand Stock

$CRCT

$6.07 -$0.08 (1.3%) Close

$CRCT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net income
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities:
Depreciation and amortization (including amortization of debt issuance costs)
Impairment of trade name
Reversal of (provision for) expected losses
Impairments
Stock-based compensation
Deferred income tax
(Gain) loss on disposal of property and equipment
Non-cash lease expense
Provision for inventory obsolescence, net
Loss on extinguishment of debt
Unrealized foreign currency (gain) / loss
Other
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued expenses, other current liabilities and other non-current liabilities
Operating lease liabilities
Deferred revenue

Net cash and cash equivalents provided by operating activities
Cash flows from investing activities:
Purchase of marketable securities
Proceeds from maturities of marketable securities
Proceeds from sales of marketable securities
Purchases of property and equipment, including capitalized software development costs
Net cash and cash equivalents provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from capital contributions
Proceeds from issuance of common stock upon initial public offering, net of offering costs
Repurchases of common stock
Repurchase of compensatory units
Proceeds from exercise of stock options
Employee tax withholding payments on stock-based awards
Payments on term loan
Drawdowns on revolving loan
Payments on revolving loan
Payments on capital leases
Payments for debt issuance costs
Cash dividend
Other financing activities, net
Net cash and cash equivalents used in financing activities

Effect of exchange rate on changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosures of cash flow information:
Cash paid during the period for interest
Cash paid during the period for income taxes
Supplemental disclosures of non-cash investing and financing activities:
Right-of-use assets obtained in exchange for new operating lease liabilities
Refinance of credit facility
Property and equipment included in accounts payable, accrued expenses and other current liabilities
Tax withholdings on stock-based awards included in accrued expenses and other current liabilities
Stock-based compensation capitalized for software development costs
Deferred offering costs in accounts payable and accrued expenses and other current liabilities
Reclassification of liability awards to equity upon modification
Leasehold improvements acquired through tenant allowances
Purchased unit equivalents issued in settlement of bonus

Comments